Moderna expects to start late-stage COVID-19 vaccine trial on July 27
14 Jul 2020 / 23:31 H.
NEW YORK, July 14 (Reuters) - Moderna Inc said on Tuesday that it plans to start late stage clinical trial for its COVID-19 vaccine candidate on or around July 27, according to its listing for the phase 3 study at clinicaltrials.gov.
Moderna said it will conduct the trial at 87 study locations, all in the U.S. (Reporting by Michael Erman, Editing by Franklin Paul)
Did you like this article?
